Near-Infrared Dye-Labeled Anti-Prostate Stem Cell Antigen Minibody Enables Real-Time Fluorescence Imaging and Targeted Surgery in Translational Mouse Models

Abstract

The inability to intraoperatively distinguish primary tumor, as well as lymphatic spread, increases the probability of positive surgical margins, tumor recurrence, and surgical toxicity. The goal of this study was to develop a tumor-specific optical probe for real-time fluorescence-guided surgery.

Document Details

Document Type
Pub Defense Publication
Publication Date
Jan 01, 2019
Source ID
10.1158/1078-0432.ccr-18-1382

Entities

People

  • Anna M. Wu
  • Chau P. Tran
  • Chung Wang
  • Evelyn A. Kono
  • Johnny Guan
  • Joyce M. Yamashiro
  • Kirstin A Zettlitz
  • Mo Zhang
  • Naoko Kobayashi
  • Robert E. Reiter
  • Wen-Ting K Tsai
  • Ziyue K. Jiang

Organizations

  • China Medical University
  • National Institutes of Health
  • United States Department of Defense
  • University of California, Los Angeles

Tags

Readers

  • Chemistry (specifically Chemical Fluorescence)
  • Neurotrauma and Rehabilitation Medicine.
  • Oncology (Cancer Research).

Technology Areas

  • Biotechnology
  • Biotechnology - Cancer Biotech